share_log

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROYSTON IVOR

SEC ·  Sep 12, 2024 17:14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more